NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

THRD

Third Harmonic Bio Inc

Apr 29 • 04:00PM ET

5.15

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Peers: BEAM NTLA CRSP EDIT SGMO VERV ONC ALNY ARCT PSTX

| Held by: IWM VTI VXF IWN IBB SCHA VTWO IWC AVSC DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.09	Insider Own	52.86%	Shs Outstand	44.86M	Perf Week	-0.19%
Market Cap	232.31M	Forward P/E	-	EPS next Y	-0.94	Insider Trans	-4.04%	Shs Float	21.26M	Perf Month	46.72%
Income	-45.47M	PEG	-	EPS next Q	-0.26	Inst Own	51.69%	Short Float	8.07%	Perf Quarter	-2.65%
Sales	0.00M	P/S	-	EPS this Y	15.29%	Inst Trans	4.84%	Short Ratio	1.93	Perf Half Y	-60.60%
Book/sh	6.36	P/B	0.81	EPS next Y	-2.17%	ROA	-15.89%	Short Interest	1.72M	Perf Year	-50.76%
Cash/sh	6.32	P/C	0.81	EPS next 5Y	-0.64%	ROE	-16.41%	52W Range	3.18 - 16.94	Perf YTD	-49.95%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-34.70%	ROI	-15.82%	52W High	-69.60%	Beta	2.16
Dividend TTM	-	Quick Ratio	40.87	Sales past 5Y	0.00%	Gross Margin	-	52W Low	61.95%	ATR (14)	0.17
Dividend Ex-Date	-	Current Ratio	40.87	EPS Y/Y TTM	-14.76%	Oper. Margin	-	RSI (14)	79.27	Volatility	0.90% 3.36%
Employees	53	Debt/Eq	0.01	Sales Y/Y TTM	-	Profit Margin	-	Recom	2.50	Target Price	4.58
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-70.68%	Payout	-	Rel Volume	0.25	Prev Close	5.15
Sales Surprise	-	EPS Surprise	18.42%	Sales Q/Q	-	Earnings	Mar 27 BMO	Avg Volume	887.76K	Price	5.15
SMA20	17.05%	SMA50	33.36%	SMA200	-44.98%	Trades		Volume	224,017	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-28-25	Downgrade	Stifel	Buy → Hold	$23 → $5
Feb-12-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$20 → $5
Feb-11-25	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-09-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$12 → $20
Jun-18-24	Initiated	Stifel	Buy	$23
Jun-07-24	Initiated	Raymond James	Outperform	$18
Dec-16-22	Downgrade	Jefferies	Buy → Hold	$30 → $3.60
Dec-15-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$5
Oct-10-22	Initiated	Morgan Stanley	Overweight	$34
Oct-10-22	Initiated	Jefferies	Buy	$30
Oct-10-22	Initiated	Cowen	Outperform

Show Previous Ratings

Apr-14-25 07:55AM	Third Harmonic outlines plans for dissolution (BioPharma Dive) +39.84%
06:45AM	Third Harmonic Bio Announces Plan of Liquidation and Dissolution (GlobeNewswire)
Mar-27-25 08:10AM	Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-04-25 09:35AM	Third Harmonic Bio, Inc. (THRD) Loses -31.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Feb-14-25 12:00PM	Third Harmonic Bio, Inc. (THRD) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
09:35AM	Loading…
09:35AM	Down -39.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Third Harmonic Bio, Inc. (THRD) (Zacks)
Feb-12-25 04:41PM	Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape (Benzinga) +9.23%
Feb-11-25 07:00AM	Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update (GlobeNewswire) -30.11%
06:38AM	Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK (BioPharma Dive)
Feb-01-25 12:07AM	Soho House, Third Harmonic Bio, and More Stocks See Action From Activist Investors (Barrons.com)
Nov-25-24 04:00PM	Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference (GlobeNewswire)
Nov-11-24 09:55AM	Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade (Zacks)
Nov-07-24 04:00PM	Third Harmonic Bio to Participate in Upcoming Investor Conferences in November (GlobeNewswire) +7.68%
08:10AM	Third Harmonic Bio Announces Third Quarter 2024 Financial Results (GlobeNewswire)
Sep-10-24 04:00PM	Third Harmonic Bio to Participate in Upcoming Investor Conferences in September (GlobeNewswire)
04:00PM	Loading…
Aug-26-24 04:00PM	Third Harmonic Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-08-24 08:05AM	Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-28-24 04:05PM	Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-20-24 04:36PM	Third Harmonic Bio Insider Sold Shares Worth $331,066, According to a Recent SEC Filing (MT Newswires) +7.92%
May-15-24 12:52PM	THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q1 2024 (InvestorPlace)
08:05AM	Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-10-24 07:02PM	Insider Sale: CEO Natalie Holles Sells Shares of Third Harmonic Bio Inc (THRD) (GuruFocus.com)
Apr-15-24 07:00PM	Third Harmonic Bio Inc CEO Natalie Holles Sells 13,558 Shares (GuruFocus.com)
Mar-28-24 08:30AM	Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors (GlobeNewswire)
Mar-26-24 09:02PM	Third Harmonic Bio Inc (THRD) Reports Decreased Net Loss in Q4, Aligns with Analyst Projections (GuruFocus.com) +5.46%
01:53PM	THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q4 2023 (InvestorPlace)
08:05AM	Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-26-24 04:00PM	Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference (GlobeNewswire)
Jan-04-24 08:00AM	Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update (GlobeNewswire)
Dec-29-23 12:00PM	Are You Looking for a Top Momentum Pick? Why Third Harmonic Bio, Inc. (THRD) is a Great Choice (Zacks)
01:05PM	Loading…
Dec-08-23 01:05PM	Insider Sell Alert: Third Harmonic Bio Inc's Julie Person Divests 12,863 Shares (GuruFocus.com) +5.40%
Nov-09-23 09:30AM	Third Harmonic Bio Inc (THRD) Reports Q3 2023 Financial Results and Continues Progress Towards ... (GuruFocus.com)
08:30AM	Third Harmonic Bio Announces Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-31-23 08:30AM	Third Harmonic Bio Announces Leadership Changes (GlobeNewswire) -9.22%
Aug-31-23 08:30AM	Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-10-23 08:10AM	Third Harmonic Bio Announces Second Quarter 2023 Financial Results (GlobeNewswire) -7.00%
Jul-26-23 09:40AM	Target downgraded, Spotify upgraded: Wall Street's top analyst calls (The Fly) +9.11%
Jul-25-23 08:30AM	Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335 (GlobeNewswire) +5.26%
Jun-09-23 08:04AM	10 Struggling IPOs To Buy For The Long-Term (Insider Monkey)
May-24-23 11:02AM	We Think Third Harmonic Bio (NASDAQ:THRD) Can Afford To Drive Business Growth (Simply Wall St.)
May-11-23 05:00PM	Third Harmonic Bio Announces First Quarter 2023 Financial Results (GlobeNewswire) -7.32%
Mar-29-23 08:05AM	Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results (GlobeNewswire)
Dec-23-22 06:32AM	Daily Vickers Top Buyers & Sellers for 12/23/2022 (Argus Research)
Dec-22-22 05:41AM	The Petri Dish: Third Harmonic axes lead program; bluebird moves forward with 3rd drug (American City Business Journals)
Dec-15-22 10:10AM	Third Harmonic Bio Stock Plummets After Trial Discontinuation On Safety Concerns (Benzinga) -78.28%
09:53AM	Third Harmonic Plunges Almost 80% After Ending Study for Skin-Inflammation Drug (Bloomberg)
08:49AM	We Think Third Harmonic Bio (NASDAQ:THRD) Can Afford To Drive Business Growth (Simply Wall St.)
08:22AM	Third Harmonic's stock falls 75% after discontinuing clinical trial (MarketWatch)
07:00AM	Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria (GlobeNewswire)
Nov-21-22 04:05PM	Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference (GlobeNewswire)
Nov-09-22 04:15PM	Third Harmonic Bio Announces Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-02-22 08:01AM	These Bases, Breakouts And Buy Zones Offer Fresh Opportunities (Investor's Business Daily) -6.14%
Sep-19-22 04:10PM	Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares (GlobeNewswire) -5.56%
Sep-15-22 11:41AM	Third Harmonic Bio stock opens more than 20% above IPO price (MarketWatch)
07:58AM	Third Harmonic Bio prices upsized IPO at $17 a share, midpoint of range (MarketWatch)

Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. The company was founded on April 25, 2019 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Conner Edward R.	Chief Medical Officer	Nov 08 '24	Option Exercise	4.20	2,117	8,891	2,117	Nov 12 05:08 PM
Conner Edward R.	Chief Medical Officer	Nov 08 '24	Sale	15.00	2,117	31,755	0	Nov 12 05:08 PM
BVF PARTNERS L P/IL	See Explanation of Responses	Oct 29 '24	Sale	14.30	1,000,000	14,300,000	176,692	Oct 31 05:53 PM
Conner Edward R.	Chief Medical Officer	Oct 28 '24	Option Exercise	4.20	2,673	11,227	2,673	Oct 30 04:17 PM
Conner Edward R.	Chief Medical Officer	Oct 28 '24	Sale	15.00	2,673	40,095	0	Oct 30 04:17 PM
EDWARD CONNER	Officer	Oct 28 '24	Proposed Sale	13.15	4,790	62,988		Oct 28 04:37 PM
Conner Edward R.	Chief Medical Officer	Sep 19 '24	Option Exercise	4.20	4,790	20,118	4,790	Sep 20 05:36 PM
Conner Edward R.	Chief Medical Officer	Sep 19 '24	Sale	15.00	4,790	71,850	0	Sep 20 05:36 PM
Person Julie	CHIEF ADMINISTRATIVE OFFICER	Sep 18 '24	Option Exercise	4.20	503	2,113	503	Sep 20 05:35 PM
Person Julie	CHIEF ADMINISTRATIVE OFFICER	Sep 19 '24	Sale	14.29	9,497	135,685	0	Sep 20 05:35 PM
Person Julie	CHIEF ADMINISTRATIVE OFFICER	Sep 18 '24	Sale	14.00	503	7,042	0	Sep 20 05:35 PM
EDWARD CONNER	Officer	Sep 19 '24	Proposed Sale	13.50	4,790	64,665		Sep 19 04:27 PM
JULIE PERSON	Officer	Sep 18 '24	Proposed Sale	12.75	10,000	127,500		Sep 18 04:37 PM
Person Julie	CHIEF ADMINISTRATIVE OFFICER	Jun 26 '24	Option Exercise	4.20	10,000	42,000	10,000	Jun 28 04:51 PM
Person Julie	CHIEF ADMINISTRATIVE OFFICER	Jun 26 '24	Sale	12.46	10,000	124,569	0	Jun 28 04:51 PM
Dittman Jennifer	Chief Development Oper Officer	Jun 07 '24	Sale	14.17	494	7,000	0	Jun 10 04:26 PM
Dittman Jennifer	Chief Development Oper Officer	May 20 '24	Sale	14.00	1,042	14,588	0	May 22 04:36 PM
Dittman Jennifer	Chief Development Oper Officer	May 16 '24	Sale	14.04	23,578	331,066	0	May 20 04:33 PM
Holles Natalie C.	CEO	May 09 '24	Option Exercise	4.20	20,222	84,932	1,239,058	May 10 04:04 PM
Holles Natalie C.	CEO	May 09 '24	Sale	12.18	20,222	246,300	1,218,836	May 10 04:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

THRD

Third Harmonic Bio Inc

Upgrade your FINVIZ experience